Hemab Therapeutics Holdings, Inc. (COAG)

NASDAQ: COAG · Real-Time Price · USD

25.89

-0.41 (-1.56%)

At close: May 22, 2026, 4:00 PM EDT

27.02

+1.13 (4.36%)

After-hours: May 22, 2026, 6:37 PM EDT

COAG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	49.86	87.97	74.41
Short-Term Investments	113.67	97.51	13.92
Cash & Short-Term Investments	163.53	185.49	88.33
Cash Growth	85.15%	110.00%	-
Other Current Assets	5.9	7.07	4.91
Total Current Assets	169.43	192.55	93.24
Net Property, Plant & Equipment	1.59	1.7	2.57
Other Long-Term Assets	4.24	0.53	0.48
Total Assets	175.26	194.78	96.28
Accounts Payable	5.68	5.73	3.16
Accrued Expenses	6.96	4.3	2.86
Current Portion of Leases	0.54	0.65	0.67
Total Current Liabilities	13.19	10.68	6.69
Long-Term Leases	0.52	0.57	1.06
Other Long-Term Liabilities	-	-	0.06
Total Long-Term Liabilities	0.52	0.57	1.12
Total Liabilities	13.71	11.25	7.8
Common Stock	-	0.13	0.13
Additional Paid-in Capital	6.37	4.92	2.91
Accumulated Other Comprehensive Income	-0.44	0.18	-0.37
Retained Earnings	-204.55	-181.86	-117.95
Total Common Shareholders' Equity	-198.62	-176.64	-115.27
Minority Interest	360.17	360.17	203.75
Shareholders' Equity	161.55	183.53	88.47
Total Liabilities & Equity	175.26	194.78	96.28

Updated May 21, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q